Head of Evidence Generation - International Region

About Ipsen

Ipsen is a mid‑size global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation. Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human‑centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success.

About the Role

The Head of Evidence Generation – International will lead the development and direction of the Ipsen International (EX US & Canada) evidence generation strategy (Phase IV, ISS, RWE) to support Ipsen’s medical objectives across all therapeutic areas (Oncology, Rare diseases and Neurotoxins). This role is pivotal in shaping and delivering high‑quality clinical and real‑world evidence (RWE) that informs decision‑making, supports access, and enhances patient outcomes. The role requires strong leadership, scientific rigor, and cross‑functional collaboration to ensure alignment with global strategies and local market needs.

Key Responsibilities

• Strategic Leadership: Responsible for developing strategies for evidence generation (Phase IV, ISS, RWE) at International that support healthcare clinical evidence gaps and the LCM of our products.
• Assess the local needs and build a proposal for scaling RWE capabilities (HC, resources, operating model) at international countries.
• Define and implement the International Evidence Generation Plan (IEGP) in alignment with global medical strategies and local evidence needs.
• Provide budget input for activities related to epidemiology and RWE studies and initiatives ensuring projects are adequately resourced.
• Evidence Generation Execution: Ensure that the Global IEGP is well implemented at local level and that country data gaps are well integrated in the IEGP (Global & Local) in alignment with lifecycle management (LCM) priorities.
• Oversee the planning, execution, and reporting of evidence generation projects (clinical studies, RWE, health outcomes research) across the region.
• Ensure scientific, ethical, and regulatory standards are met in all research activities.
• Support country teams in project design and EGRB submission readiness.
• Cross‑Functional Collaboration: Partner with country medical directors, asset medical leads, market access, clinical operations, and HEOR to align evidence generation with business objectives.
• Capability Building: Lead the development of RWE capabilities at the local/regional level, including operating models, resources, and trainings.
• External Engagement: Identify key research opportunities, including clinical studies, real‑world evidence projects, and health outcomes research, and foster partnerships and collaborations with institutions at International.
• Proactively identify, evaluate, and secure access to high‑quality external data sources.

Qualifications

• Advanced degree in life sciences, medicine, epidemiology, or a related field (MD, PharmD, PhD preferred).
• Extensive experience in medical affairs, clinical research, RWE or HEOR within the pharmaceutical industry.
• Proven track record in leading regional or global evidence generation strategies.
• Experience with RWE, observational studies, and regulatory‑grade data generation.
• Demonstrated strong leadership and experience in designing and conducting Phase IV, pharmaco‑epidemiology studies in support of pre‑/post‑approval evidence‑generating activities; expert in data collection methods and strong familiarity with secondary data sources.
• Experience leading external analytic and evidence‑generating activities.
• Excellent data analytic skills, including knowledge of standard statistical software and packages (SAS, R, etc.).
• Demonstrated experience in innovative and design thinking.
• Demonstrated ability to collaborate in a matrix and remote organizations.
• Exceptional critical thinking to help identify gaps, analyze findings and make recommendations while articulating next steps.
• Deep understanding of international regulatory and payer evidence requirements.
• Excellent communication and stakeholder engagement skills.
• English fluency. #LI‑HYBRID.

Diversity & Inclusion

Nous nous engageons à créer un lieu de travail où chacun se sent écouté, valorisé et soutenu, où nous incarnons « The Real Us ».